[Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?]. (Record no. 19995217)

MARC details
000 -LEADER
fixed length control field 01393 a2200337 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515233044.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201101s 0 0 fre d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1769-664X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S0929-693X(10)70033-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bader-Meunier, B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20110106
245 00 - TITLE STATEMENT
Title [Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Date of publication, distribution, etc. Jun 2010
300 ## - PHYSICAL DESCRIPTION
Extent 632-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenal Cortex Hormones
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents, Non-Steroidal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antirheumatic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Evidence-Based Medicine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxychloroquine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunosuppressive Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Long-Term Care
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lupus Erythematosus, Systemic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lupus Nephritis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mycophenolic Acid
General subdivision analogs & derivatives
773 0# - HOST ITEM ENTRY
Title Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Related parts vol. 17
-- no. 6
-- p. 632-3
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S0929-693X(10)70033-6">https://doi.org/10.1016/S0929-693X(10)70033-6</a>
Public note Available from publisher's website

No items available.